文献
J-GLOBAL ID:202102273123872454
整理番号:21A0470917
進行部位局所治療は,オリゴ転移性去勢抵抗性前立腺癌におけるその後のアンドロゲン受容体軸標的薬の有効性を延長できるか?
Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer?
著者 (7件):
Yoshida Soichiro
(Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan)
,
Takahara Taro
(Department of Biomedical Engineering, Tokai University School of Engineering, Kanagawa, Japan)
,
Takahara Taro
(Department of Radiology, Advanced Imaging Center, Yaesu Clinic, Tokyo, Japan)
,
Yokoyama Minato
(Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan)
,
Matsuoka Yoh
(Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan)
,
Yoshimura Ryoichi
(Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, Tokyo, Japan)
,
Fujii Yasuhisa
(Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan)
資料名:
International Journal of Urology (Web)
(International Journal of Urology (Web))
巻:
28
号:
2
ページ:
241-242
発行年:
2021年
JST資料番号:
U0707A
ISSN:
1442-2042
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)